8-K
Current Report
C4 Therapeutics, Inc. Filed Acc 0001564590-21-033633
Shareholder vote results · Regulation FD disclosure
- Item 5.07 Submission of matters to a vote of security holders
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading cccc-8k_20210615.htm…